Table 4.
Relation between rs2046211 with Hormonal Receptors in Breast Cancer Group (n = 60)
| rs2046211 | Test of significance (p) | ||
|---|---|---|---|
| CC (n = 54) n (%) |
CG (n = 6) n (%) |
||
| ER | |||
| Negative | 6 (11.1) | 4 (66.7) | FEp= 0.005* |
| Positive | 48 (88.9) | 2 (33.3) | |
| PR | |||
| Negative | 20 (37.0) | 4 (66.7) | FEp= 0.206 |
| Positive | 34 (63.0) | 2 (33.3) | |
| HER-2 | |||
| Negative | 48 (88.9) | 4 (66.7) | FEp= 0.178 |
| Positive | 6 (11.1) | 2 (33.3) | |
| Combinations | |||
| -ER,-PR,-HER-2 | 4 (7.4) | 2 (33.3) | |
| -ER,-PR,+HER-2 | 2 (3.7) | 2 (33.3) | |
| +ER,-PR,-HER-2 | 14 (25.9) | 0 (0.0) | MCp=0.020* |
| +ER,+PR,-HER-2 | 30 (55.6) | 2 (33.3) | |
| +ER,+PR,+HER-2 | 4 (7.4) | 0 (0.0) | |
χ2, Chi square test; MC, Monte Carlo; FE, Fisher Exact; p, p value for comparing between different genotypes